Irofulven in Treating Patients With Metastatic Colorectal Cancer

NCT00003441 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Irofulven (MGI-114)

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]